Direkt zum Inhalt
Merck

HPLC Analysis of Aripiprazole and Dehydro Aripiprazole Using a Titan C18 Column

HPLC Analysis of Aripiprazole and Dehydro Aripiprazole Using a Titan C18 Column application for HPLC

Materialien

used together

Produkt-Nr.
Beschreibung
Preisangaben

Ammoniumformat

eluent additive for LC-MS, LiChropur, ≥99.0%

Ähnliches Produkt

Produkt-Nr.
Beschreibung
Preisangaben

Dehydro aripiprazole solution

1.0 mg/mL in methanol with 5% 1 M HCl, ampule of 1 mL, certified reference material, Cerilliant®

Aripiprazole solution

1.0 mg/mL (50:50 Methanol/Water with 1% 1N HCl), ampule of 1 mL, certified reference material, Cerilliant®

CONDITIONS

column

Titan C18, 10 cm x 3.0 mm I.D., 1.9 μm particles (577160-U)

mobile phase

[A] 10 mM ammonium formate; pH 3.0 with formic acid [B] 0.1% formic acid in methanol

gradient

40% B for 0.5 minutes followed by a linear gradient to 95% B for 3.5 minutes, followed by a hold at 95% B for 2 minutes.

flow rate

0.5 mL/min

pressure

6500 psi (445 bar)

column temp.

35 °C

detector

UV, 245 nm

injection

2 μL

sample

50 μg/mL in 10% methanol

Beschreibung

Hinweis zur Analyse

Aripiprazole is marketed as the atypical antipsychotic Abilify® for the treatment of schizophrenia, bipolar disorder and clinical depression. Dehydroapiprazole is the primary metabolite of Aripiprazole.

Rechtliche Hinweise

Abilify is a registered trademark of Otsuka Pharmaceutical Co.
null